That sound derogatory.
Did you expect her to go into detail about serotonin, what the latest Science tells us it does, what serotonin uptake inhibitors do, etc?
The woman wrote an article that is really just an ice breaker on how she and her partner dealt with acknowledging that there was a depression problem and getting help for it. She felt that her contribution to the problem of depression was to relay a little of Wil Wheaton's story from her perspective.
but they also fail to help a great number more
No one has said that every case is the same. In fact, TFA specifically mentions that fact as well as anecdotally telling us about how Wil had to change his dosage and medication to meet his specific and dynamic neurological profile.
That "sticks shaped these ways" happen to affect neurotransmitter levels is a great guide to finding others, especially the great moves in safety from MAO inhibitors -> trycyclics and the like -> 3rd generation started with Prozac, is sort of besides the point. That they make a really significant difference for lots of people is.
Not that wikipedia is the last word, but, "[...] companies such as Pfizer continue to promote drugs like Zoloft with advertisements asserting that mental illness may be due to chemical imbalances in the brain, and that their drugs work to "correct" this imbalance. Most academics believe that the advertisements are oversimplified and don't fully explain what is happening."
Oversimplifications
I was simply pointing you to a reference that showed that "academics" use the exact same language regarding chemical balance of neurotransmitters as the original author.
Notice that it didn't say, "Academics disregard the chemical balance explanation because it lacks evidentiary support."
>Notice that it didn't say, "Academics disregard the chemical balance explanation because it lacks evidentiary support."
A lack of explicit critique in a rephrasing on wikipedia should not be used as evidence.
The cited article for that sentence (http://www.medscape.com/viewarticle/516262) is from 2005 and includes the following:
> Numerous studies to identify reproducible changes in neurotransmitter levels in the cerebrospinal fluid of clinically depressed patients, or to induce or correct depression by manipulating brain serotonin levels, were inconclusive and fraught with methodological limitations.
> Gordon McCarter, PhD, an assistant professor of biological sciences at the College of Pharmacy of Touro University in Vallejo, California, agreed that the evidence for an "imbalance" in neurotransmitters causing depression is "circumstantial" and "more and more tenuous." He noted the dearth of studies showing any measurable difference in serotonin or norepinephrine between depressed patients and controls
> "The Diagnostic and Statistical Manual of Mental Disorders does not list serotonin as a cause of any mental disorder; it is simply one neurotransmitter that continues to be investigated. And the prescribing information for the SSRIs does not claim that their mechanism of action is to correct a chemical imbalance, although this is exactly what the advertisements claim."
> "We suspect that many consumers believe the serotonin theory to be more scientifically based than it is, and that they might have chosen an alternative approach to their distress if they were fully informed.
Ronald Pies, MD, psychiatry professor at SUNY Upstate Medical University and Tufts University School of Medicine, and editor of the Psychiatric Times.
http://www.psychiatrictimes.com/blogs/couch-crisis/psychiatr...
SSRIs increase levels of serotonin at the synapse when administered by preventing serotonin re-uptake and recycling, improving mood.
SSREs decrease levels of serotonin at the synapse when administered by enhancing serotonin re uptake and recycling, improving mood.
Two drugs with opposite effects achieve the same qualitative result, even though it can't be said that they produce similar quantitative results. Thus, vastly different quantitative profiles are correlated with the same qualitative results; X + 1 = X - 1.
On top of that, there's no way to even measure levels of synaptic neurotransmitters in vivo.
That said, too much or too little serotonin absorbed by a specific set or another can have wildly different effects.
Too much serotonin is not a good thing. So you need to balance it. For some people, this means SSRIs, for some it means SSREs. That's the explanation for the imbalance model, and it does make sense given the science.
Sure, blast a brain with drugs that aren't well understood and it'll behave differently, maybe "better" than before, relatively speaking-- but that's not a scientific model so much as a pragmatic clinical solution.
Sure, dump in a bunch of spices that aren't measured and it'll taste different, maybe "better" than before, relatively speaking--but that's not a scientific model so much as a pragmatic cooking solution.
SSRIs bind to the serotonin transporter SERT. The 'selective' part means that it has a much higher affinity for SERT than other monoamine transporters (e.g., DAT or NET). Although you're correct that there are various serotonin receptor subtypes, there is only one known SERT (there is only one gene).
SSRIs do exhibit extremely weak affinity to serotonin receptors but it is so low that it doesn't matter which subtype has a higher affinity than another. If you want to latch on to 5HT receptors with interesting ratios and affinities, the correct psychiatric drug would be an antipsychotic.
Please stop defending the chemical imbalance model when you do not understand the science at all. Thank you.
The only problem with this is that it's essentially a PR line that both doctors and the general public have mistaken for science. We don't know all that many facts about how brain chemicals work with regard to mood disorders. We have empirical results from clinical trials and broad use of antidepressant and antipsychotic medications, but there is no basis to believe that medications "balancing out those chemicals" serve to repair mood disorders.
If the medications helped, then great, I know they have helped a great number of people, but they also fail to help a great number more and these success stories have an unfortunate tendency to marginalize people that do not get good results from medication. It often results in victim-blaming, to make sufferers of depression wrong for stopping their medications for legitimate reasons (let's face it, all of these results are highly subjective), and for overstating the ability of our current medications to cure all mental ills.